Preparation method of 2-formamido thienopyridine derivatives and medical uses

A technology of phenopyridine and its derivatives, which is applied in the field of preparation of antitumor pharmaceutical compositions of 2-formamidothienopyridine derivatives, and can solve the problems that there are no reports on the medical use of 2-formamidothienopyridine derivatives , to achieve good market prospects and good anti-tumor effect

Inactive Publication Date: 2010-03-31
SICHUAN UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] There is no report on the medical use of this compound and other 2-formamidothienopyridine derivatives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of 2-formamido thienopyridine derivatives and medical uses
  • Preparation method of 2-formamido thienopyridine derivatives and medical uses
  • Preparation method of 2-formamido thienopyridine derivatives and medical uses

Examples

Experimental program
Comparison scheme
Effect test

preparation Embodiment 3

[0033] Preparation Example 3-Amino-N-(4-chlorobenzyl)-7-(3-methoxyphenyl)-4H-thiophene[2,3-b]pyridine-2-carboxamide (SKLB-703) preparation of

[0034] The 2-carboxamidothienopyridine derivatives used in the present invention were synthesized by the inventors themselves, with a relative molecular mass of 423.915 and a structural formula as shown in Formula II:

[0035]

[0036] The preparation method of the compound of formula II is: take p-methoxyacetophenone 1 as raw material, first react with N,N-dimethylformamide dimethyl acetal (DMF-DMA) to obtain enaminone 2, and then react with Cyanothioacetamide was ring-closed to obtain 3, and then condensed with amide 5 to obtain the target product of thienopyridines. The 3-step reaction gave the target product of formula II with a total yield of 32%.

[0037] Experimental operation and data part:

[0038] 1, the preparation of enaminone:

[0039] P-methoxyacetophenone 1 (3.19g, 21.2mmol) and N,N-dimethylformamide dimethyl aceta...

experiment Embodiment 12

[0058] Experimental Example 12-In vitro tumor cell proliferation inhibition experiment of carboxamidothienopyridine derivatives

[0059] 1. Experimental materials

[0060] 1.1 Main reagents

[0061] RPMI-1640, DMEM, fetal calf serum, and trypsin were purchased from Gibco BRL (Invitrogen Corporation, USA), brominated thiazolyl blue tetrazolium (MTT) and dimethyl sulfoxide (DMSO) were products of Sigma Corporation (USA). 2-Carboxamidothienopyridine derivatives were purchased from Specs Company (Netherlands) and were used as chemical standards. During in vitro experiments, they were prepared as 20 mg / ml storage solution with DMSO, stored in a refrigerator at 4°C in the dark for future use, and used for complete culture before use. diluted to the desired concentration.

[0062] 1.2 Cell lines and culture

[0063] Human liver cancer cell line (HepG2), human prostate cancer cell line (PC-3), human breast cancer cell line (MCF-7), human lung cancer cell line (A549), human colon ca...

experiment Embodiment 22

[0072] Experimental example 22-In vivo anti-tumor experiment of carboxamidothienopyridine derivatives

[0073] 1. Experimental materials

[0074] See Experimental Example 1.

[0075] 2.1 Experimental method

[0076] Establish a mouse tumor model: a mouse Lewis lung cancer model. The animal model uses female C57BL / 6 mice aged 6-8 weeks and weighing about 18-20 g. purchased from West China Animal Experiment Center, Sichuan University. Raised in the animal room of the laboratory, the animals were free to eat and drink, and the night and day alternated. The experiment began after the animals adapted to the environment. Inoculate LL / 2 cells subcutaneously into the rear flank of mice, each inoculate about 5×105 cells (0.1ml), and when the tumor grows to be palpable, divide the mice into two groups randomly: solvent control group, 60mg / kg SKLB-703 treatment group, 10 rats in each group. SKLB-703 was dissolved in 20% PEG and 10% ethanol solution and administered intraperitoneall...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses preparation method of 2-formamido thienopyridine derivatives and uses in preparing antineoplastic medicine compositions, The experiment results show that the 2-formamido thienopyridine derivatives has antitumor action, which can be used as main active components to prepare new antineoplastic medicine and provide new selection for treatment of tumour.

Description

technical field [0001] The invention belongs to the field of medicine, and specifically relates to the use of 2-formamidothienopyridine derivatives in the preparation of antitumor pharmaceutical compositions. Background technique [0002] Malignant tumors have become an important killer that endangers human health and survival. Especially in recent years, with the deterioration of the environment, the incidence of malignant tumors has shown an obvious upward trend. Although with the application of new generation chemotherapeutic drugs such as paclitaxel, gemcitabine, Gleevec, etc., the survival of patients has gained certain benefits, the prognosis of most cancer patients is still poor and the mortality rate is high, typically such as liver cancer and prostate cancer Wait. Therefore, it has become an urgent task to develop new anti-tumor drugs, especially those with new parent structures, or to screen new anti-tumor drugs from existing compounds. [0003] The inventors hav...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D495/04A61K31/4365A61P35/00
Inventor 杨胜勇杨黎赵赢兰余洛汀魏于全
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap